Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sexton

Showing results (501-510 of 518) with videos related to

Pageof 52
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Structure-based discovery of selective positive allosteric modulators of antagonists for the M<sub>2</sub> muscarinic acetylcholine receptorMagdalena Korczynska, Mary J Clark, Celine Valant, et al.
ACS Pharmacology & Translational Science|March 29, 2020
The Molecular Control of Calcitonin Receptor SignalingEmma Dal Maso, Alisa Glukhova, Yue Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
<i>In vivo</i> functional profiling and structural characterisation of the human <i>Glp1r</i> A316T variantLiliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
Nature|January 10, 2020
Activation of the GLP-1 receptor by a non-peptidic agonistPeishen Zhao, Yi-Lynn Liang, Matthew J Belousoff, et al.
Molecular Cell|October 7, 2020
Differential GLP-1R Binding and Activation by Peptide and Non-peptide AgonistsXin Zhang, Matthew J Belousoff, Peishen Zhao, et al.
BMJ Open Diabetes Research & Care|November 16, 2021
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanismsDarren M Riddy, Helene L Kammoun, Andrew J Murphy, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
ACS Chemical Neuroscience|April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide ScaffoldAaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
Science Advances|February 4, 2026
In vivo functional profiling and structural characterization of the human <i>GLP1R</i> A316T variantLiliane El Eid, Yusman Manchanda, Gregory Austin, et al.
Pageof 52

Showing results (501-510 of 518) with videos related to

Sort By:
Pageof 52
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Structure-based discovery of selective positive allosteric modulators of antagonists for the M<sub>2</sub> muscarinic acetylcholine receptorMagdalena Korczynska, Mary J Clark, Celine Valant, et al.
ACS Pharmacology & Translational Science|March 29, 2020
The Molecular Control of Calcitonin Receptor SignalingEmma Dal Maso, Alisa Glukhova, Yue Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
<i>In vivo</i> functional profiling and structural characterisation of the human <i>Glp1r</i> A316T variantLiliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
Nature|January 10, 2020
Activation of the GLP-1 receptor by a non-peptidic agonistPeishen Zhao, Yi-Lynn Liang, Matthew J Belousoff, et al.
Molecular Cell|October 7, 2020
Differential GLP-1R Binding and Activation by Peptide and Non-peptide AgonistsXin Zhang, Matthew J Belousoff, Peishen Zhao, et al.
BMJ Open Diabetes Research & Care|November 16, 2021
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanismsDarren M Riddy, Helene L Kammoun, Andrew J Murphy, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
ACS Chemical Neuroscience|April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide ScaffoldAaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
Science Advances|February 4, 2026
In vivo functional profiling and structural characterization of the human <i>GLP1R</i> A316T variantLiliane El Eid, Yusman Manchanda, Gregory Austin, et al.
Pageof 52